Back

Prognosis of atrial fibrillation with or without comorbidities. Analysis of younger adults from a nationwide database

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Atrial fibrillation in context of concomitant medical conditions Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Laurent Fauchier

University Hospital of Tours, Tours (France)

7 More presentations in this session

Presentation thumbnail
Impact of diabetes and glucose-lowering therapy on post-operative atrial fibrillation after cardiac surgery: secondary analysis of the SEARCH-AF CardioLink-1 randomized clinical trial
Mr A. Pandey (Hamilton, CA)
Abstract Slides
Presentation thumbnail
Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation
Doctor R. Nishinarita (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Sodium-glucose cotransporter 2 inhibitors not only suppress recurrence after atrial fibrillation ablation but also cause atrial reverse remodeling
Associate Professor T. Mine (Nishinomiya, JP)
Abstract Slides
Presentation thumbnail
Development of the new risk score to predict occurrence of atrial fibrillation early after acute myocardial infarction.
Doctor K. Iwakura (Osaka, JP)
Abstract Slides
Presentation thumbnail
Influence of obesity and overweight on the association between sleep-disordered breathing and atrial fibrillation: the DASAP-HF study
Professor G. Boriani (Modena, IT)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation in context of concomitant medical conditions

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources